Gail Boudreaux and Sarah London: The Women at the Top of US Healthcare
The two largest woman-led companies in America are not in technology or retail. They are health insurers, together bringing in nearly $400 billion a year and covering tens of millions of people.

Executive Key Takeaways
- Elevance Health (No. 18) and Centene (No. 19) are the largest woman-led companies in the Fortune 500.
- Elevance raised its 2026 outlook despite Medicaid cost pressures.
- Centene's marketplace membership fell by 2.4 million after subsidies expired, but its earnings are recovering.
- Both CEOs rank on Fortune's 2026 Most Powerful Women list.
For years, General Motors was the highest-ranked woman-led company in the Fortune 500. In 2026, two health insurers overtook it. Elevance Health ranks No. 18 with $199 billion in revenue, and Centene No. 19 with $195 billion. Both are led by women: Gail Boudreaux and Sarah London.
Their companies rarely make headlines the way tech giants do. Yet the decisions these two leaders make shape the healthcare coverage of millions of Americans, from employer health plans to Medicaid and Medicare. In an industry facing intense financial and political pressure, their jobs are among the most demanding in American business.
Gail Boudreaux: steady hands at Elevance
Boudreaux took over as chief executive of Anthem in 2017, after a long career in health insurance that included leading UnitedHealthcare, one of the country's largest insurers. A former college basketball standout at Dartmouth, she has a reputation for discipline and long-term focus. Under her leadership, the company renamed itself Elevance Health in 2022 to reflect its broader ambitions beyond traditional insurance.
Those ambitions centre on Carelon, Elevance's health services business, which manages pharmacy benefits, behavioural health and care for people with complex needs. The company argues that integrating insurance with services helps control costs and improve care.
2026 has tested that strategy. Medical costs have risen sharply across the industry, particularly in Medicaid, where Elevance expects this year to be the low point. The company has agreed to exit the District of Columbia's Medicaid market and expects to leave additional markets over the next 12 to 18 months.
Even so, Elevance has outperformed expectations. In the second quarter, it raised its 2026 earnings outlook to at least $27 in adjusted earnings per share, on operating revenue of $49.8 billion. Its Medicare Advantage business beat forecasts, and it reported a record year for winning large national employer accounts. Fortune ranks Boudreaux No. 81 on its 2026 Most Powerful Women list.
Sarah London: rebuilding Centene
Sarah London became Centene's chief executive in 2022, after joining the company from UnitedHealth Group's Optum, where she worked on data and analytics. At the time, she was one of the youngest chief executives in the Fortune 500.
Centene is the largest provider of Medicaid managed care and a major player in the Affordable Care Act marketplaces. Those markets have been hit hard. When enhanced federal premium tax credits expired at the start of 2026, many people dropped their coverage. Centene's marketplace membership fell from 5.8 million to 3.4 million in a year.
The financial impact was severe. In 2025, Centene took a $6.7 billion goodwill impairment, resulting in a large full-year loss. The company offered voluntary buyouts across its workforce, reducing headcount from about 61,000 to 53,900.
“Solid underlying fundamentals within our core businesses have powered a faster recovery,” London said.
The recovery is now under way. In October 2026, Centene raised its full-year earnings guidance to more than $5.20 in adjusted earnings per share, on quarterly revenue of $50.6 billion. Medicaid remains its largest business, with 11.9 million members, and its Medicare prescription drug plans grew to 8.9 million members.
London has kept faith with the individual market despite its turmoil. “We haven’t changed our commitment to this product,” she said. Fortune ranks her No. 63 on its 2026 Most Powerful Women list.
An industry under pressure
Both leaders face the same headwinds: rising medical costs, policy changes in Washington, new Medicaid work requirements due in January 2027, and public frustration with the cost of care. Their decisions involve trade-offs between affordability, access and financial sustainability that few other executives face.
What leaders can learn
Influence does not always come with headlines. Boudreaux and London show that some of the most powerful leaders in business run companies most people only think about when they need them. Their work is a reminder that steady, disciplined leadership in complex, regulated industries can be just as consequential as the moves that dominate the news.
“Solid underlying fundamentals within our core businesses have powered a faster recovery.”
Frequently Asked Questions
Key Questions Answered
Related Research & Coverage
Explore Further
More in Industry Spotlight
Jane Fraser: The Banker Who Rebuilt Citi
When she took charge in 2021, plenty of people doubted anyone could fix Citigroup. Five years later, she is ranked the most powerful woman in business, and Citi is talking about growth again.
Kiran Mazumdar-Shaw: From a Bengaluru Garage to Global Biopharma
She started Biocon in 1978 with little more than a garage and a stubborn idea. Nearly five decades later, she is shaping its next chapter, and choosing who will lead it.
